FDA approves new blood sugar medication for individuals with type 2 diabetes

The U.S. Food and Drug Administration (FDA) has approved a new drug for improving blood sugar control among people with type 2 diabetes, according to a recent article published by Medical News Today.

The medication, called Tradjenta, may be used along with a diabetes diet and exercise program, and can be taken in combination with several other diabetes treatments, including metformin, sulfonylurea or pioglitazone, the news provider reported.

Studies have shown that the medication reduces hemoglobin A1c levels by 0.7 percent in individuals with type 2 diabetes, but does not provide benefits for patients who have diabetic ketoacidosis or type 1 diabetes, the news source explained.

"Many people with type 2 diabetes are not able to control their blood sugar with diet and exercise alone and may also require one or more medications. The FDA approval of Tradjenta is exciting because there is only one dose to remember for all patients, regardless of kidney or liver impairment," said John Gerich, MD, quoted by the news organization.

Individuals who were recently diagnosed with type 2 diabetes may find it difficult to become accustomed to monitoring their blood sugar levels. However, the Mayo Clinic offers some advice for everyday diabetes management that is focused on three simple areas - food, exercise and medications.

The foundation recommends that diabetics eat with consistency. For example, consuming a standard amount of food at the same time each day may help individuals predict the hours at which their blood glucose levels will be the highest or lowest.

While physical activity is recommended for people who have type 2 diabetes, the organization notes that diligent blood sugar monitoring is key before, during and after exercise. Diabetics should ask their physicians whether they need to adjust their insulin doses before exercise or wait a few hours to work out after taking these types of injections.

The Mayo Clinic also states that individuals who receive non-diabetes medications should always ask their doctors or pharmacists if these drugs may affect their blood sugar levels.